vs

Side-by-side financial comparison of DT Midstream, Inc. (DTM) and Guardian Pharmacy Services, Inc. (GRDN). Click either name above to swap in a different company.

Guardian Pharmacy Services, Inc. is the larger business by last-quarter revenue ($336.6M vs $317.0M, roughly 1.1× DT Midstream, Inc.). DT Midstream, Inc. runs the higher net margin — 35.0% vs 4.0%, a 31.0% gap on every dollar of revenue. On growth, DT Midstream, Inc. posted the faster year-over-year revenue change (27.3% vs 2.2%).

Oneok, Inc. ONE-oak, stylized as ONEOK, is an American oil and gas midstream operator headquartered in Tulsa, Oklahoma. It provides the oil and gas industry with gathering, processing, fractionation, transportation, and storage services. The company is part of the Fortune 500 and S&P 500. Oneok was founded as Oklahoma Natural Gas Company in 1906, but it changed its corporate name to Oneok in 1980.

CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, Massachusetts, in 1963.

DTM vs GRDN — Head-to-Head

Bigger by revenue
GRDN
GRDN
1.1× larger
GRDN
$336.6M
$317.0M
DTM
Growing faster (revenue YoY)
DTM
DTM
+25.1% gap
DTM
27.3%
2.2%
GRDN
Higher net margin
DTM
DTM
31.0% more per $
DTM
35.0%
4.0%
GRDN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
DTM
DTM
GRDN
GRDN
Revenue
$317.0M
$336.6M
Net Profit
$111.0M
$13.5M
Gross Margin
22.7%
Operating Margin
49.2%
5.3%
Net Margin
35.0%
4.0%
Revenue YoY
27.3%
2.2%
Net Profit YoY
52.1%
46.1%
EPS (diluted)
$1.07
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DTM
DTM
GRDN
GRDN
Q1 26
$336.6M
Q4 25
$317.0M
$397.6M
Q3 25
$314.0M
$377.4M
Q2 25
$309.0M
$344.3M
Q1 25
$303.0M
$329.3M
Q4 24
$249.0M
Q3 24
$248.0M
$314.4M
Q2 24
$244.0M
Net Profit
DTM
DTM
GRDN
GRDN
Q1 26
$13.5M
Q4 25
$111.0M
$20.9M
Q3 25
$115.0M
$9.8M
Q2 25
$107.0M
$9.0M
Q1 25
$108.0M
$9.4M
Q4 24
$73.0M
Q3 24
$88.0M
$-122.0M
Q2 24
$96.0M
Gross Margin
DTM
DTM
GRDN
GRDN
Q1 26
22.7%
Q4 25
21.5%
Q3 25
19.8%
Q2 25
19.8%
Q1 25
19.5%
Q4 24
Q3 24
19.4%
Q2 24
Operating Margin
DTM
DTM
GRDN
GRDN
Q1 26
5.3%
Q4 25
49.2%
7.7%
Q3 25
49.4%
4.3%
Q2 25
50.2%
3.7%
Q1 25
48.8%
3.9%
Q4 24
45.4%
Q3 24
49.2%
-33.3%
Q2 24
53.3%
Net Margin
DTM
DTM
GRDN
GRDN
Q1 26
4.0%
Q4 25
35.0%
5.3%
Q3 25
36.6%
2.6%
Q2 25
34.6%
2.6%
Q1 25
35.6%
2.9%
Q4 24
29.3%
Q3 24
35.5%
-38.8%
Q2 24
39.3%
EPS (diluted)
DTM
DTM
GRDN
GRDN
Q1 26
$0.21
Q4 25
$1.07
Q3 25
$1.13
Q2 25
$1.04
Q1 25
$1.06
Q4 24
$0.73
Q3 24
$0.90
Q2 24
$0.98

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DTM
DTM
GRDN
GRDN
Cash + ST InvestmentsLiquidity on hand
$54.0M
$64.9M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.7B
$232.4M
Total Assets
$10.1B
$426.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DTM
DTM
GRDN
GRDN
Q1 26
$64.9M
Q4 25
$54.0M
$65.6M
Q3 25
$98.0M
$36.5M
Q2 25
$74.0M
$18.8M
Q1 25
$83.0M
$14.0M
Q4 24
$68.0M
Q3 24
$77.0M
$37.2M
Q2 24
$73.0M
Total Debt
DTM
DTM
GRDN
GRDN
Q1 26
Q4 25
$0
Q3 25
Q2 25
Q1 25
Q4 24
$3.4B
Q3 24
$34.3M
Q2 24
Stockholders' Equity
DTM
DTM
GRDN
GRDN
Q1 26
$232.4M
Q4 25
$4.7B
$217.9M
Q3 25
$4.7B
$195.5M
Q2 25
$4.7B
$179.7M
Q1 25
$4.6B
$163.2M
Q4 24
$4.6B
Q3 24
$4.2B
$133.9M
Q2 24
$4.2B
Total Assets
DTM
DTM
GRDN
GRDN
Q1 26
$426.9M
Q4 25
$10.1B
$412.7M
Q3 25
$10.1B
$390.0M
Q2 25
$10.0B
$356.3M
Q1 25
$9.9B
$334.0M
Q4 24
$9.9B
Q3 24
$8.6B
$348.0M
Q2 24
$9.0B
Debt / Equity
DTM
DTM
GRDN
GRDN
Q1 26
Q4 25
0.00×
Q3 25
Q2 25
Q1 25
Q4 24
0.72×
Q3 24
0.26×
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DTM
DTM
GRDN
GRDN
Operating Cash FlowLast quarter
$161.0M
$6.1M
Free Cash FlowOCF − Capex
$30.0M
FCF MarginFCF / Revenue
9.5%
Capex IntensityCapex / Revenue
41.3%
Cash ConversionOCF / Net Profit
1.45×
0.45×
TTM Free Cash FlowTrailing 4 quarters
$441.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DTM
DTM
GRDN
GRDN
Q1 26
$6.1M
Q4 25
$161.0M
$34.6M
Q3 25
$274.0M
$28.2M
Q2 25
$185.0M
$19.9M
Q1 25
$247.0M
$17.6M
Q4 24
$152.0M
Q3 24
$205.0M
Q2 24
$165.0M
Free Cash Flow
DTM
DTM
GRDN
GRDN
Q1 26
Q4 25
$30.0M
Q3 25
$131.0M
$24.2M
Q2 25
$104.0M
Q1 25
$176.0M
Q4 24
$62.0M
Q3 24
$124.0M
Q2 24
$84.0M
FCF Margin
DTM
DTM
GRDN
GRDN
Q1 26
Q4 25
9.5%
Q3 25
41.7%
6.4%
Q2 25
33.7%
Q1 25
58.1%
Q4 24
24.9%
Q3 24
50.0%
Q2 24
34.4%
Capex Intensity
DTM
DTM
GRDN
GRDN
Q1 26
Q4 25
41.3%
Q3 25
45.5%
1.1%
Q2 25
26.2%
Q1 25
23.4%
Q4 24
36.1%
Q3 24
32.7%
Q2 24
33.2%
Cash Conversion
DTM
DTM
GRDN
GRDN
Q1 26
0.45×
Q4 25
1.45×
1.65×
Q3 25
2.38×
2.87×
Q2 25
1.73×
2.21×
Q1 25
2.29×
1.86×
Q4 24
2.08×
Q3 24
2.33×
Q2 24
1.72×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DTM
DTM

Pipeline Segment$173.0M55%
Gathering Segment$144.0M45%

GRDN
GRDN

Segment breakdown not available.

Related Comparisons